MATTHEW HAROLD KATZ to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications MATTHEW HAROLD KATZ has written about Antimetabolites, Antineoplastic.
Connection Strength
0.406
-
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science. 2017 09 15; 357(6356):1156-1160.
Score: 0.098
-
Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer. Phys Biol. 2014 Nov 26; 11(6):065002.
Score: 0.080
-
Efficacy of Salmonella typhimurium A1-R versus chemotherapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX). J Cell Biochem. 2014 Jul; 115(7):1254-61.
Score: 0.078
-
Transport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest. 2014 Apr; 124(4):1525-36.
Score: 0.076
-
Exercise during preoperative therapy increases tumor vascularity in pancreatic tumor patients. Sci Rep. 2019 09 27; 9(1):13966.
Score: 0.028
-
Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline. J Clin Oncol. 2019 04 20; 37(12):1015-1027.
Score: 0.027
-
A retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy. Ann Oncol. 2013 Sep; 24(9):2349-53.
Score: 0.018